Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1485-1489

  Bruins Slot, M H E ^a   Rutten, F H ^a   Van Der Heijden, G J M G ^a   Doevendans, P A ^a   Mast, E G ^b   Bredero, A C ^c   Van Der Spoel, O P ^a   Glatz, J F C ^d   Hoes, A W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acute coronary syndrome; Biomarker; Diagnosis; H FABP; Primary care

Indexed keywords

FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIVARIATE ANALYSIS; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RAPID TEST; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYMPTOM;

ACUTE CORONARY SYNDROME; BIOMARKER; DIAGNOSIS; H-FABP; PRIMARY CARE;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PRIMARY HEALTH CARE;

EID: 84885316990     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.050     Document Type: Article

References (20)

1. Culic V, Eterovic D, Miric D, Silic N. Symptom presentation of acute myocardial Infarction: Influence of sex, age, and risk factors. Am Heart J 2002;144:1012-7.
2. Bassand JP, HammCW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28: 1598-660.
3. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial Infarction redefined-a consensus document of The JoInt European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
4. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed In collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50:e1-157.
5. Bleeker JK, Simoons ML, Erdman RA, et al. Patient and doctor delay In acute myocardial Infarction: a study In Rotterdam, The Netherlands. Br J Gen Pract 1995;45:181-4.
6. Broer J, Bleeker JK, Bouma J, de Jongste MJ, Erdman RA, Meyboom-de JB. Regional differences In prehospital time delay for patients with acute myocardial Infarction; Rotterdam and Groningen, 1990-1995. Ned Tijdschr Geneeskd 2000;144:78-83.
7. Hitchcock T, Rossouw F, McCoubrie D, Meek S. Observational study of prehospital delays In patients with chest pain. Emerg Med J 2003;20:270-3.
8. Glatz JF, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acutemyocardial Infarction. Clin Chim Acta 1998;272:87-92.
9. van Nieuwenhoven FA, Kleine AH, Wodzig WH, et al. Discrimination between myocardial and skeletal muscle Injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995;92:2848-54.
10. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue Injury. Clin Chim Acta 2005;352:15-35.
11. Chan CP, Sum KW, Cheung KY, et al. Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. J Immunol Methods 2003;279:91-100.
12. Bruins Slot MHE, van der Heijden GJ, Rutten FH, et al. Heart-type fatty acid-binding protein In acute myocardial Infarction evaluation (FAME): background and design of a diagnostic study In primary care. BMC Cardiovasc Disord 2008;8:8.
13. Grijseels EW, Deckers JW, Hoes AW, et al. Implementation of a pre-hospital decision rule In general practice. Triage of patients with suspected myocardial Infarction. Eur Heart J 1996;17:89-95.
14. Alhashemi JA. Diagnostic accuracy of a bedside qualitative Immunochromatographic test for acute myocardial Infarction. Am J Emerg Med 2006;24:149-55.
15. Ecollan P, Collet JP, Boon G, et al. Pre-hospital detection of acutemyocardial Infarction with ultra-rapid human fatty acid-binding protein (H-FABP) Immunoassay. Int J Cardiol 2007;119:349-54.
16. Lefevre G, Fayet JM, Graine H, et al. Multicenter evaluation of h-FABP semiquantitative assay (Cardio Detect) In central laboratory: the poInt In acute myocardial Infarction diagnosis. Ann Biol Clin (Paris) 2007;65:377-84.
17. Mad P, Domanovits H, Fazelnia C, et al. Human heart-type fatty-acid-binding protein as a poInt-of-care test In the early diagnosis of acute myocardial Infarction. QJM 2007;100:203-10.
18. Naroo GY, Ali SM, Butros V, et al. Elevated heart-type fatty acid-binding protein predicts early myocardial Injury and aids In the diagnosis of non-ST elevation myocardial Infarction. Hong Kong J Emerg Med 2009;16:141-7.
19. Valle HA, Riesgo LG, Bel MS, Gonzalo FE, SanchezMS, Oliva Li. Clinical assessment of heart-type fatty acid binding protein In early diagnosis of acute coronary syndrome. Eur J Emerg Med 2008;15:140-4.
20. Thygesen K, Alpert JS,White HD. Universal definition of myocardial Infarction. J Am Coll Cardiol 2007;50:2173-95.